|
1
|
Damron TA, Ward WG and Stewart A:
Osteosarcoma, chon-drosarcoma, and Ewing's sarcoma: National Cancer
Data Base Report. Clin Orthop Relat Res. 459:40–47. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mirabello L, Troisi RJ and Savage SA:
International osteosarcoma incidence patterns in children and
adolescents, middle ages and elderly persons. Int J Cancer.
125:229–234. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Eyre R, Feltbower RG, Mubwandarikwa E,
Eden TO and McNally RJ: Epidemiology of bone tumours in children
and young adults. Pediatr Blood Cancer. 53:941–952. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Joliot V, Martinerie C, Dambrine G,
Plassiart G, Brisac M, Crochet J and Perbal B: Proviral
rearrangements and overexpression of a new cellular gene (nov) in
myeloblastosis-associated virus type 1-induced nephroblastomas. Mol
Cell Biol. 12:10–21. 1992.PubMed/NCBI
|
|
5
|
Perbal B: NOV (nephroblastoma
overexpressed) and the CCN family of genes: Structural and
functional issues. Mol Pathol. 54:57–79. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen CC and Lau LF: Functions and
mechanisms of action of CCN matricellular proteins. Int J Biochem
Cell Biol. 41:771–783. 2009. View Article : Google Scholar :
|
|
7
|
Ouellet V, Tiedemann K, Mourskaia A, Fong
JE, Tran-Thanh D, Amir E, Clemons M, Perbal B, Komarova SV and
Siegel PM: CCN3 impairs osteoblast and stimulates osteoclast
differentiation to favor breast cancer metastasis to bone. Am J
Pathol. 178:2377–2388. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Scholz G, Martinerie C, Perbal B and
Hanafusa H: Transcriptional down regulation of the nov
proto-oncogene in fibroblasts transformed by p60v-src. Mol Cell
Biol. 16:481–486. 1996.PubMed/NCBI
|
|
9
|
Chevalier G, Yeger H, Martinerie C,
Laurent M, Alami J, Schofield PN and Perbal B: novH: Differential
expression in developing kidney and Wilm's tumors. Am J Pathol.
152:1563–1575. 1998.PubMed/NCBI
|
|
10
|
Manara MC, Perbal B, Benini S, Strammiello
R, Cerisano V, Perdichizzi S, Serra M, Astolfi A, Bertoni F, Alami
J, et al: The expression of ccn3(nov) gene in musculoskeletal
tumors. Am J Pathol. 160:849–859. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yu C, Le AT, Yeger H, Perbal B and Alman
BA: NOV (CCN3) regulation in the growth plate and CCN family member
expression in cartilage neoplasia. J Pathol. 201:609–615. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu S, Liu Z, Bi D, Yuan X, Liu X, Ding S,
Lu J and Niu Z: CCN3 (NOV) regulates proliferation, adhesion,
migration and invasion in clear cell renal cell carcinoma. Oncol
Lett. 3:1099–1104. 2012.PubMed/NCBI
|
|
13
|
Benini S, Perbal B, Zambelli D, Colombo
MP, Manara MC, Serra M, Parenza M, Martinez V, Picci P and
Scotlandi K: In Ewing's sarcoma CCN3(NOV) inhibits proliferation
while promoting migration and invasion of the same cell type.
Oncogene. 24:4349–4361. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu C, Liu X-J, Crowe PD, Kelner GS, Fan
J, Barry G, Manu F, Ling N, De Souza EB and Maki RA: Nephroblastoma
overexpressed gene (NOV) codes for a growth factor that induces
protein tyrosine phosphorylation. Gene. 238:471–478. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ren Z, Hou Y, Ma S, Tao Y, Li J, Cao H and
Ji L: Effects of CCN3 on fibroblast proliferation, apoptosis and
extracellular matrix production. Int J Mol Med. 33:1607–1612.
2014.PubMed/NCBI
|
|
16
|
Owen TA, Aronow M, Shalhoub V, Barone LM,
Wilming L, Tassinari MS, Kennedy MB, Pockwinse S, Lian JB and Stein
GS: Progressive development of the rat osteoblast phenotype in
vitro: Reciprocal relationships in expression of genes associated
with osteoblast proliferation and differentiation during formation
of the bone extracellular matrix. J Cell Physiol. 143:420–430.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Perbal B, Zuntini M, Zambelli D, Serra M,
Sciandra M, Cantiani L, Lucarelli E, Picci P and Scotlandi K:
Prognostic value of CCN3 in osteosarcoma. Clin Cancer Res.
14:701–709. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kuo WH, Chen JH, Lin HH, Chen BC, Hsu JD
and Wang CJ: Induction of apoptosis in the lung tissue from rats
exposed to cigarette smoke involves p38/JNK MAPK pathway. Chem Biol
Interact. 155:31–42. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mansouri A, Ridgway LD, Korapati AL, Zhang
Q, Tian L, Wang Y, Siddik ZH, Mills GB and Claret FX: Sustained
activation of JNK/p38 MAPK pathways in response to cisplatin leads
to Fas ligand induction and cell death in ovarian carcinoma cells.
J Biol Chem. 278:19245–19256. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen HJ, Lin CM, Lee CY, Shih NC, Peng SF,
Tsuzuki M, Amagaya S, Huang WW and Yang JS: Kaempferol suppresses
cell metastasis via inhibition of the ERK-p38-JNK and AP-1
signaling pathways in U-2 OS human osteosarcoma cells. Oncol Rep.
30:925–932. 2013.PubMed/NCBI
|
|
21
|
Tsagaraki I, Tsilibary EC and Tzinia AK:
TIMP-1 interaction with αvβ3 integrin confers resistance to human
osteosarcoma cell line MG-63 against TNF-α-induced apoptosis. Cell
Tissue Res. 342:87–96. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Luo J, Deng ZL, Luo X, Tang N, Song WX,
Chen J, Sharff KA, Luu HH, Haydon RC, Kinzler KW, et al: A protocol
for rapid generation of recombinant adenoviruses using the AdEasy
system. Nat Protoc. 2:1236–1247. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
He TC, Zhou S, da Costa LT, Yu J, Kinzler
KW and Vogelstein B: A simplified system for generating recombinant
adenoviruses. Proc Natl Acad Sci USA. 95:2509–2514. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fidler IJ: The pathogenesis of cancer
metastasis: The 'seed and soil' hypothesis revisited. Nat Rev
Cancer. 3:453–458. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Perbal B: The CCN3 protein and cancer. New
Trends in Cancer for the 21st Century; Springer; pp. 23–40.
2006
|
|
27
|
Denduluri SK, Idowu O, Wang Z, Liao Z, Yan
Z, Mohammed MK, Ye J, Wei Q, Wang J, Zhao L, et al: Insulin-like
growth factor (IGF) signaling in tumorigenesis and the development
of cancer drug resistance. Genes Dis. 2:13–25. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Perbal B: CCN proteins: A centralized
communication network. J Cell Commun Signal. 7:169–177. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bartek J and Lukas J: Mammalian G1- and
S-phase checkpoints in response to DNA damage. Curr Opin Cell Biol.
13:738–747. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yin X-M, Oltvai ZN and Korsmeyer SJ: BH1
and BH2 domains of Bcl-2 are required for inhibition of apoptosis
and heterodimerization with Bax. Nature. 369:321–323. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kroemer G: The proto-oncogene Bcl-2 and
its role in regulating apoptosis. Nat Med. 3:614–620. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wagner EF and Nebreda ÁR: Signal
integration by JNK and p38 MAPK pathways in cancer development. Nat
Rev Cancer. 9:537–549. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
De Chiara G, Marcocci ME, Torcia M,
Lucibello M, Rosini P, Bonini P, Higashimoto Y, Damonte G,
Armirotti A, Amodei S, et al: Bcl-2 phosphorylation by p38 MAPK:
Identification of target sites and biologic consequences. J Biol
Chem. 281:21353–21361. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Nicholson DW and Thornberry NA: Apoptosis.
Life and death decisions. Science. 299:214–215. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Doghman M, Arhatte M, Thibout H, Rodrigues
G, De Moura J, Grosso S, West AN, Laurent M, Mas JC, Bongain A, et
al: Nephroblastoma overexpressed/cysteine-rich protein
61/connective tissue growth factor/nephroblastoma overexpressed
gene-3 (NOV/CCN3), a selective adrenocortical cell proapoptotic
factor, is downregulated in childhood adrenocortical tumors. J Clin
Endocrinol Metab. 92:3253–3260. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gupta N, Wang H, McLeod TL, Naus CC,
Kyurkchiev S, Advani S, Yu J, Perbal B and Weichselbaum RR:
Inhibition of glioma cell growth and tumorigenic potential by CCN3
(NOV). Mol Pathol. 54:293–299. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen PC, Cheng HC and Tang CH: CCN3
promotes prostate cancer bone metastasis by modulating the
tumor-bone microenvironment through RANKL-dependent pathway.
Carcinogenesis. 34:1669–1679. 2013. View Article : Google Scholar : PubMed/NCBI
|
